Janusz Jankowski
| Janusz Jankowski | |
|---|---|
| Born | Glasgow, Scotland |
| Nationality | British and European |
| Fields |
Clinical Trials Gastroenterology Genomics Health promotion Education Academic Administration |
| Alma mater |
University of Glasgow University of Dundee University of London University of Oxford |
| Known for |
|
Janusz Jankowski MBChB, MSc, MD, PhD, FRCP, AGAF, FACG, SFHEA and PGCE is a doctor, educationalist, executive director and scientist of Scottish Polish origin. His current role is Pro Vice Chancellor Research as well as Professor of Medicine.[1] He was formerly an Associate Dean Research and the Sir James Black Professor. He has also held several opinion-forming positions including chairmanship of National Academic, Clinical, Education and Research Committees.[2]
Education and qualifications
Jankowski was state educated at Hillhead High School, Glasgow. He was the first pupil for many years to gain a place at medical school, which was also precocious as it occurred shortly after his 17th birthday. He graduated from the University of Glasgow with a Bachelorette in Medicine and Surgery (1983).[2] He undertook research at the University of Dundee and was awarded a Doctorate of Medicine in Molecular Medicine (1996) and subsequently completed a Doctorate of Philosophy in Molecular Genetics at the Royal Postgraduate Medical School, Imperial College at the University of London (1996).[2] He has trained at the University of Oxford also gaining a Masters of Science in Epidemiology and Clinical Trials (2009).[2] He has been awarded Fellowships by UK and American Medical Colleges; Fellow of the Royal College of Physicians London (2000), Fellow of the American College of Gastroenterology USA (2007) and American Gastroenterology Association Fellow (2012).[2]
Jankowski has several educational qualifications including a Post Graduate Certificate in Medical Education PGCE from the University of Cambridge (2013) and a Senior Fellowship from the Higher Education Academy (2014).
He is certified in many aspects of senior management including Gerard Egan mentoring and John Adair actioned-centred functional leadership.[2]
Career and academic management
He has held Professorships at the University of Birmingham, University of Leicester and Queen Mary University of London. He has been a Visiting Professor and then the Sir James Black Senior Fellow at the University of Oxford. Following this he has been in senior management as the Associate Dean for Research at the Plymouth University Peninsula Schools of Medicine and Dentistry, England, UK and then the Associate Dean for Research and Special Projects in Health and Life Sciences at Coventry University, England, UK with an Honorary Professorship at the University of Warwick.
Jankowski is currently the inaugural Pro Vice Chancellor Research at the University of Central Lancashire as well as the Professor of Medicine at the United Kingdoms newest Medical School in the same Institution. In the NHS partner organisation he is also a Consultant Physician (Gastroenterologist) and Director for Research, Development and Innovation at North Cumbria University Hospitals.[3] He now delivers Research Leadership across 5 Colleges; 1. Schools of Business, Law and Applied Social Sciences, 2. Schools of Medicine, Dentistry, Clinical and Biomedical Sciences, 3. Schools of Nursing, Health and Wellbeing, 4. Schools of Art, Humanities, Culture and Creative Industries and 5. Schools of Science, Psychology and Technology. Over 20 years he has helped raise £100m+ in funds.[4]
In these posts he had many strategic roles in wide aspects of research focus, governance, education, student satisfaction, recruitment, planning, leadership, mentoring and enterprise. Jankowski is proven in change management (including culture, infrastructure development, sustainability and research services). His scientific team and alliance building has allowed transformational developments in academia.[2] This includes the ChOPIN/EAGLE Consortia with over 100 Worldwide centres.[5]
Jankowski had a pivotal senior management contribution to the Research Excellence Framework 2014 as the Clinical Medicine (UoA1) Lead for the Plymouth University Peninsula Schools of Medicine and Dentistry (PUPSMD). Crucially PUPSMD was ranked in 1st place out of 31 UK Universities for the Grade Point Average Score (GPA) of the Clinical Medicine Research Outputs (3.33 vs 3.21 for the nearest competitor) [6] This advantage was mainly in the 4* World Class range, based upon the quality of the publications and the number of citations. As a whole PUPSMD ranked in joint 13th place, out of 31 as calculated from the Overall Profile GPA, for wider contributions including Environment, Research Impact as well as Outputs.[7]
Clinician and teacher
Jankowski is an expert in reflux esophagitis, Barrett's esophagus, acute medicine and clinical trials as well as more generally in cancer prevention and health promotion. As a clinician Professor Jankowski has helped create centres of excellence in medicine and gastroenterology especially the Digestive Disease Centre, University Hospitals of Leicester 2002–2012. He set up Scotlands first endoscopic surveillance service for Barrett's esophagus (ESBE) between 1988–1991 at Ninewells Hospital of Dundee as well as Londons first ESBE between 1991–1994 at Guy's Hospital both of which still run to this date.
In the national arena Jankowski has supported the National Institute for Health and Care Excellence (NICE) in producing authoritative guidelines and technology reviews in many key medical areas. Recently he has published independent guidance for the National Health Service (NHS) and other international organisations using the largest evidence based Delphi systematic review platforms.[8]
Jankowski has been an editor of several innovative and authoritative text books including those in gastroenterology and gastrointestinal cancer.[9]
Research and publications
Prof Jankowski's group have undertaken several important innovative studies including the isolation of label retaining cells (putative stem cells) in the oesophagus [10] identification of the genomic factors associated with the premalignant condition Barrett's oesophagus.[11] They are currently studying the use of aspirin in a large novel randomized clinical trial to prevent cancer.[12]
Prof Jankowski is a highly cited clinical academic with a h-index of over 55.[13] He has over 200 publications of which 150 are peer reviewed papers including those in high impact scientific journals such as Gastroenterology, The Lancet, Lancet Oncology, Nature, Nature Genetics, Nature Communications, New England Journal of Medicine and Proceedings of the National Academy of Sciences USA.[14]
Awards and honours
Jankowski has been awarded several Prizes most notably NHS Clinical Excellence Awards, the Sir Francis Avery Jones Award (British Society of Gastroenterology), the James Black Senior Fellowship (University of Oxford) and the Sir James Black Professorship (Plymouth University).[2]
Pro bono roles and directorships
Jankowski has had many community roles on a pro bono basis for example as a sports medicine doctor especially in inter school rugby. In Tae Kwon Do he is also a 1st Dan black belt and supports health and fitness both within and outside the sport.[15][16][17] He has had several office-based roles as a school governor, parish councillor and charity trustee. In this latter case he was an active Executive Director of Fight Oesophageal Reflux Together national support group for patients with gastroesophageal reflux disease (www.fortcharity.org.uk).[18]
Jankowski has been chairman of several national committee boards including the Acute and Chronic Diseases Panel of NICE, the GI Cancer Prevention Committee of the National Cancer Research Network and the Education Committee of the British Society of Gastroenterology.[2]
Jankowski has been a member of many funding councils both in the UK and overseas. He is currently chair of the European Union TRANSCAN-2 funding committee.[19]
References
- ↑ "Executive Team Janusz Jankowski=http://www.uclan.ac.uk/executive/index.php".
- 1 2 3 4 5 6 7 8 9 "Janusz Jankowski". Plymouth University. Retrieved 19 October 2014.
- ↑ "UClan Medical School Academic Staff". Retrieved 20 June 2016.
- ↑ "University of Warwick Academic Staff". Retrieved 2 December 2014.
- ↑ "Clinical Research Networks UK". Retrieved 2 December 2014.
- ↑ "Times REF 2014 Highlinghts". Retrieved 21 January 2014.
- ↑ "REF 2014 Results". Retrieved 18 December 2014.
- ↑ "National Institute of Health and Care Excellence Approved; The Barrett's dysplasia and cancer taskforce (BAD CAT) consensus group" (PDF). Retrieved 2 December 2014.
- ↑ "Janusz Jankowski Books". Retrieved 2 December 2014.
- ↑ Janusz Jankowski et al, (2013). "Identification of lineage uncommitted, long lived, label retaining cells in the healthy human esophagus and stomach, and in the metaplastic esophagus". Gastroenterology: 761–7. doi:10.1053/j.gastro.2012.12.022.
- ↑ Janusz Jankowski et al, (2012). "Common variants at the MHC locus predispose to Barrett's esophagus". Nature Genetics: 1131–6. doi:10.1038/ng.2408. Retrieved 19 October 2014.
- ↑ Janusz Jankowski; Hugh Barr; Ken Wang; Brendan Delaney (2010). "Diagnosis and management of Barrett's oesophagus". British Medical Journal: 341. doi:10.1136/bmj.c4551. Retrieved 19 October 2014.
- ↑ "Janusz Jankowski Citation and Hirsch index". Retrieved 2 December 2014.
- ↑ "Janusz Jankowski Publication Profile". Retrieved 2 December 2014.
- ↑ "International TaeKwon-Do Federation". Retrieved 15 October 2015.
- ↑ "Leicester TaeKwon-Do Academy". Retrieved 14 October 2015.
- ↑ "Leicester Tae Kwon Do Promtotions". Retrieved 26 November 2015.
- ↑ "FORT". Retrieved 2 December 2014.
- ↑ "TRANSCAN2". Retrieved 1 June 2015.